Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New wound care dressing reduces use of antibiotics:

This article was originally published in Clinica

Executive Summary

Patients receiving temporary heart pumps at the Cleveland Clinic Heart Center, are being treated with Arglaes, a new wound care dressing which can reduce the incidence of infection without the use of antibiotics. The dressing releases a constant stream of silver ions to the wound site for up to seven days, forming an antimicrobial barrier. Unlike antibiotics, it does not have induced resistance to any known bacteria. Arglaes was developed by Danish company Maersk Medical and is distributed in the US by Mundelein, Illinois-based Medline Industries. The product comes in the form of a transparent film with or without an absorbent calcium alginate pad.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT075551

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel